-
1
-
-
0029039625
-
Evaluation of water-soluble pneumocandin analogs L-733550, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
-
Abruzzo, G. K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, D. Krupa, V. B. Pikounis, H. Krupp, and K. Bartizal. 1995. Evaluation of water-soluble pneumocandin analogs L-733550, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 39:1077-1081.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 1077-1081
-
-
Abruzzo, G.K.1
Flattery, A.M.2
Gill, C.J.3
Kong, L.4
Smith, J.G.5
Krupa, D.6
Pikounis, V.B.7
Krupp, H.8
Bartizal, K.9
-
2
-
-
0028233286
-
Correlation between in vitro and in vivo activity of antifungal agents against Candida species
-
Anaissie, E. J., N. C. Karyotakis, R. Hachem, M. C. Dignani, J. H. Rex, and V. Paetznick. 1994. Correlation between in vitro and in vivo activity of antifungal agents against Candida species. J. Infect. Dis. 170:384-389.
-
(1994)
J. Infect. Dis.
, vol.170
, pp. 384-389
-
-
Anaissie, E.J.1
Karyotakis, N.C.2
Hachem, R.3
Dignani, M.C.4
Rex, J.H.5
Paetznick, V.6
-
3
-
-
0029031373
-
In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373
-
Bartizal, K., T. Scott, G. K. Abruzzo, C. J. Gill, C. Pacholok, L. Lynch, and H. Kropp. 1995. In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373. Antimicrob. Agents Chemother. 39:1070-1076.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 1070-1076
-
-
Bartizal, K.1
Scott, T.2
Abruzzo, G.K.3
Gill, C.J.4
Pacholok, C.5
Lynch, L.6
Kropp, H.7
-
4
-
-
0026737730
-
Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
-
Fraser, V. J., M. Jones, J. Dunkel, S. Storfer, G. Medoff, and W. C. Dunagan. 1992. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin. Infect. Dis. 15:414-121.
-
(1992)
Clin. Infect. Dis.
, vol.15
, pp. 414-1121
-
-
Fraser, V.J.1
Jones, M.2
Dunkel, J.3
Storfer, S.4
Medoff, G.5
Dunagan, W.C.6
-
5
-
-
0342577438
-
-
Unpublished data
-
Graybill, J. R. Unpublished data.
-
-
-
Graybill, J.R.1
-
6
-
-
0027320369
-
Fluconazole resistance in Candida glabrata
-
Hitchcock, C. A., G. W. Pye, P. F. Troke, E. M. Johnson, and D. W. Warnock. 1993. Fluconazole resistance in Candida glabrata. Antimicrob. Agents Chemother. 37:1962-1965.
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 1962-1965
-
-
Hitchcock, C.A.1
Pye, G.W.2
Troke, P.F.3
Johnson, E.M.4
Warnock, D.W.5
-
7
-
-
0028149474
-
Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis
-
Kurtz, M. B., C. Douglas, J. Marrinan, K. Nollstadt, J. Onishi, S. Dreikorn, J. Milligan, S. Mandala, J. Thompson, J. M. Balkovec, F. A. Bouffard, J. F. Dropinski, M. L. Hammond, R. A. Zambias, G. Abruzzo, K. Bartizal, O. B. McManus, and M. L. Garcia. 1994. Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrob. Agents Chemother. 38:2750-2757.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 2750-2757
-
-
Kurtz, M.B.1
Douglas, C.2
Marrinan, J.3
Nollstadt, K.4
Onishi, J.5
Dreikorn, S.6
Milligan, J.7
Mandala, S.8
Thompson, J.9
Balkovec, J.M.10
Bouffard, F.A.11
Dropinski, J.F.12
Hammond, M.L.13
Zambias, R.A.14
Abruzzo, G.15
Bartizal, K.16
McManus, O.B.17
Garcia, M.L.18
-
9
-
-
0029130683
-
Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata
-
Parkinson, T., D. J. Falconer, and C. A. Hitchcock. 1995. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob. Agents Chemother. 39:1696-1699.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 1696-1699
-
-
Parkinson, T.1
Falconer, D.J.2
Hitchcock, C.A.3
-
10
-
-
0025950061
-
Fluconazole and Candida krusei fungemia
-
Persons, D. A., M. Laughlin, D. Tanner, J. Perfect, J. P. Gockerman, and J. W. Hathorn. 1993. Fluconazole and Candida krusei fungemia. N. Engl. J. Med. 325:1315.
-
(1993)
N. Engl. J. Med.
, vol.325
, pp. 1315
-
-
Persons, D.A.1
Laughlin, M.2
Tanner, D.3
Perfect, J.4
Gockerman, J.P.5
Hathorn, J.W.6
-
11
-
-
0028046352
-
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
-
Rex, J. H., J. E. Bennett, A. M. Sugar, P. G. Pappas, C. M. van der Horst, J. E. Edwards, R. G. Washburn, W. M. Scheld, A. W. Karchmer, A. P. Dine, M. J. Levenstein, and C. D. Webb. 1994. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331:1325-1330.
-
(1994)
N. Engl. J. Med.
, vol.331
, pp. 1325-1330
-
-
Rex, J.H.1
Bennett, J.E.2
Sugar, A.M.3
Pappas, P.G.4
Van Der Horst, C.M.5
Edwards, J.E.6
Washburn, R.G.7
Scheld, W.M.8
Karchmer, A.W.9
Dine, A.P.10
Levenstein, M.J.11
Webb, C.D.12
-
13
-
-
0024450044
-
Risk factors for hospital-acquired candidemia
-
Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1989. Risk factors for hospital-acquired candidemia. Arch. Intern. Med. 149:2349-2353.
-
(1989)
Arch. Intern. Med.
, vol.149
, pp. 2349-2353
-
-
Wey, S.B.1
Mori, M.2
Pfaller, M.A.3
Woolson, R.F.4
Wenzel, R.P.5
-
14
-
-
0026093688
-
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
-
Wingard, J. R., W. G. Merz, M. G. Rinaldi, T. R. Johnson, J. E. Karp, and R. Saral. 1991. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 325:1274-1277.
-
(1991)
N. Engl. J. Med.
, vol.325
, pp. 1274-1277
-
-
Wingard, J.R.1
Merz, W.G.2
Rinaldi, M.G.3
Johnson, T.R.4
Karp, J.E.5
Saral, R.6
|